Immunovant Quote - IMVTU | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Immunovant Inc (IMVTU) Share Price

Immunovant Inc (IMVTU)

30.277

0.00

(0.00%)

At close: 13 November 8:00AM

Delayed by 15 minutes

30.277

0.00

( 0.00% )

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

30.277

Bid

28.35

Offer

37.20

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

30.277

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

145,293,000

Dividend Yield

-

PE Ratio

-16.39

Earnings Per Share (EPS)

-1.78

Revenue

-

Net Profit

-259.34M

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Sector

Blank Checks

Industry

Biological Pds,ex Diagnstics

Website

www.immunovant.com

Headquarters

Wilmington, Delaware, USA

Founded

2018

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MVSTMicrovast Holdings Inc	US$ 0.3103 (71.72%)	8.17M
DAVEDave Inc	US$ 79.17 (26.07%)	44.97k
NMHINatures Miracle Holding Inc	US$ 0.1068 (24.62%)	6.45M
RKLBRocket Lab USA Inc	US$ 18.25 (24.49%)	7.33M
CYCCCyclacel Pharmaceuticals Inc	US$ 0.5002 (22.00%)	2.65M
SYRSSyros Pharmaceuticals Inc	US$ 0.3882 (-85.78%)	9.05M
VINOGaucho Group Holdings Inc	US$ 2.35 (-47.19%)	173.18k
VRMVroom Inc	US$ 5.42 (-38.90%)	47.13k
SIBNSI BONE Inc	US$ 11.50 (-26.42%)	4.8k
INSGInseego Corporation	US$ 13.69 (-24.61%)	36.51k
JGLOJP Morgan Global Select Equity ETF	US$ 63.13 (0.00%)	18.88M
SOUNSoundHound AI Inc	US$ 6.99 (-7.54%)	12.3M
LGMKLogicMark Inc	US$ 0.1688 (-5.43%)	9.43M
SYRSSyros Pharmaceuticals Inc	US$ 0.3882 (-85.78%)	9.05M
MVSTMicrovast Holdings Inc	US$ 0.3103 (71.72%)	8.17M

The_Gman

The_Gman 2 minutes ago

Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.

ignatiusrielly35

ignatiusrielly35 2 minutes ago

You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.

12yearplan

12yearplan 2 minutes ago

Sorry for the late reply; .. from your two links and thanks..

Summary.

Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f

navycmdr

navycmdr 2 minutes ago

https://x.com/InvestIt3/status/1856406733754708460

2B_unknown

2B_unknown 3 minutes ago

Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.

Hosai

Hosai 3 minutes ago

From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even

MartinLutherKing

MartinLutherKing 3 minutes ago

It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/

manibiotech

manibiotech 3 minutes ago

Yep nothing for market to be in any FOMO mode
Likely will slowly go down over next few days without news . As I also said after ASM

Groveman1

Groveman1 3 minutes ago

Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.

FeMike

FeMike 4 minutes ago

I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too

cottonisking

cottonisking 4 minutes ago

No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.

northam43

northam43 4 minutes ago

Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG

manibiotech

manibiotech 5 minutes ago

Look at section subsequent events in 10 q

Hmm

jimr1717

jimr1717 5 minutes ago

New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait

MRJ25

MRJ25 5 minutes ago

Reddit will be better.

Rebel13

Rebel13 5 minutes ago

There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!

art2426

art2426 6 minutes ago

We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"

How is reading this board, NOT FUN?

jimr1717

jimr1717 6 minutes ago

How? Watch and learn.

mrwrn2010

mrwrn2010 7 minutes ago

Blast from the past!

Mactheriverrat

Mactheriverrat 7 minutes ago

Thoughts on TLRY?

exwannabe

exwannabe 7 minutes ago

Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.

gdog

gdog 8 minutes ago

11-12 buy/cover EVH $14.19 + 4.15%

MahinAgency

MahinAgency 8 minutes ago

H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.

againstallodds

againstallodds 8 minutes ago

Market expects gold delivery, imagine if no delivery

No gold = no created value

CommodityCoverage

CommodityCoverage 8 minutes ago

Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond

United Maritime

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions